BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region

Cancer Genetics and Cytogenetics

Volumn 183, Issue 1, 2008, Pages 14-20

  Wozniak, K ^a   Piaskowski, S ^a   Gresner, S M ^a   Golanska, E ^a   Bieniek, E ^a   Bigoszewska, K ^a   Sikorska, B ^a   Szybka, M ^a   Kulczycka Wojdala, D ^a   Zakrzewska, M ^a   Zawlik, I ^a   Papierz, W ^a   Stawski, R ^a   Jaskolski, D J ^a   Och, W ^b   Sieruta, M ^a   Liberski, P P ^a   Rieske, P ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b WSS Olsztyn ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MERLIN;

ARTICLE; BCR GENE; CHROMOSOME 22Q; GENE; GENE DELETION; GENE ISOLATION; GENE LOCATION; GNAZ GENE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENINGIOMA; PRIORITY JOURNAL; RAB36 GENE; REAL TIME POLYMERASE CHAIN REACTION; RTDR1 GENE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCR;

EID: 43149095788     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.01.020     Document Type: Article

References (19)

1. Rouleau G.A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B., Pulst S.M., Lenoir G., Bijlsma E., Fashold R., Dumanski J., de Jong P., Parry D., Eldrige R., Aurias A., Delattre O., and Thomas G. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363 (1993) 515-521
2. Akagi K., Kurahashi H., Arita N., Hayakawa T., Monden M., Mori T., Takai S., and Nishisho I. Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer 60 (1995) 178-182
3. Schmitz U., Mueller W., Weber M., Sévenet N., Delattre O., and von Deimling A. INI1 mutations in meningiomas at a potential hotspot in exon 9. Br J Cancer 84 (2001) 199-201
4. Lekanne Deprez R.H., Riegman P.H.J., Groen N.A., Warringa U.L., van Biezen N.A., Molijn A.C., Bootsma D., de Jong P.J., Menon A.G., Kley N.A., Seizinger B.R., and Zwarthoff E.C. Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 10 (1995) 1521-1528
5. Rieske P., Zakrzewska M., Piaskowski S., Jaskólski D., Sikorska B., Papierz W., Zakrzewski K., and Liberski P.P. Molecular heterogeneity of meningioma with INI1 mutation. Mol Pathol 56 (2003) 299-301
6. Hansson C.M., Buckley P.G., Grigelioniene G., Piotrowski A., Hellström A.R., Mantripragada K., Jarbo C., Mathiesen T., and Dumanski J.P. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. BMC Genomics 12 (2007) 8-16
7. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., and Kleihues P. The 2007 WHO Classification of Tumors of the Central Nervous System. Acta Neuropathol (Berl) 114 (2007) 97-109
8. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30 (2002) e36
9. Ruttledge M.H., Sarrazin J., Rangaratnam S., Phelan C.M., Twist E., Merel P., Delattre O., Thomas G., Nordenskjöld M., Collins V.P., Dumanski J.P., and Rouleau G.A. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6 (1994) 180-184
10. Baldinu P., Cossu A., Manca A., Satta M.P., Sini M.C., Rozzo C., Dessole S., Cherchi P., Gianfrancesco F., Pintus A., Carboni A., Deiana A., Tanda F., and Palmieri G. Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. Hum Mutat 23 (2004) 318-326
11. van Wezel T., Lombaerts M., van Roon E.H., Philippo K., Baelde H.J., Szuhai K., Cornelisse C.J., and Cleton-Jansen A.M. Expression analysis of candidate breast tumor suppressor genes on chromosome 16q. Breast Cancer Res 7 (2005) R998-R1004
12. Morrison H., Sperka T., Manent J., Giovannini M., Ponta H., and Herrlich P. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 67 (2007) 520-527
13. Shaw R.J., Paez J.G., Curto M., Yaktine A., Pruitt W.M., Saotome I., O'Bryan J.P., Gupta V., Ratner N., Der C.J., Jacks T., and McClatchey A.I. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 1 (2001) 63-72
14. Diekmann D., Brill S., Garrett M.D., Totty N., Hsuan J., Monfries C., Hall C., Lim L., and Hall A. Bcr encodes a GTPase-activating protein for p21rac. Nature 351 (1991) 400-402
15. Cho Y.J., Cunnick J.M., Yi S.J., Kaartinen V., Groffen J., and Heisterkamp N. Abr and Bcr, two homologous Rac GTPase-activating proteins, control multiple cellular functions of murine macrophages. Mol Cell Biol 27 (2007) 899-911
16. Kaartinen V., Gonzalez-Gomez I., Voncken J.W., Haataja L., Faure E., Nagy A., Groffen J., and Heisterkamp N. Abnormal function of astroglia lacking Abr and Bcr RacGAPs. Development 128 (2001) 4217-4227
17. Ress A., and Moelling K. Bcr is a negative regulator of the Wnt signalling pathway. EMBO Rep 6 (2005) 1095-1100
18. Pećina-Šlaus N., Nikuševa Martić T., Tomas D., Beroš V., Zeljko M., and Cupić H. Meningiomas exhibit loss of heterozygosity of the APC gene. J Neurooncol (2007) 10.1007/s11060-007-9500-6
19. Mahon G.M., Wang Y., Korus M., Kostenko E., Cheng L., Sun T., Arlinghaus R.B., and Whitehead I.P. The c-Myc Oncoprotein Interacts with Bcr. Curr Biol 13 (2003) 437-441